Immunocompromised: Clinical Trials

3 trials for Immunocompromised, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Active not recruiting 1, Not yet recruiting 1, Recruiting 1

Follow Immunocompromised: new trials by email Literature Review of Immunocompromised trials Research Report on Immunocompromised

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
DaRT seeds - Squamous Cell Carcinoma, Alpha Radiation
Not applicableRecruitingAlpha Tau Medical LTD.282026-01-012026-07-15
Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immunocompromised Patients
combination therapy, SOC - COVID-19, SARS-CoV-2
Not applicableNot yet recruitingNational Taiwan University Hospital402024-09-212024-09-25
Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy
High Flow Nasal Cannula or Low Flow Nasal Cannula - Immunocompromised, Hematologic Malignancy
Not applicableActive not recruitingMount Sinai Hospital, Canada982018-01-102025-05-09

Narrower conditions

COVID-19 (1)  ·  Carcinoma, Squamous Cell (1)  ·  Hematologic Neoplasms (1)  ·  Hypoxia (1)  ·  Skin Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Carcinoma (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Squamous Cell (1)  ·  Nidovirales Infections (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)

Interventions

Combined Modality Therapy (1)  ·  Ritonavir (1)  ·  nirmatrelvir (1)  ·  remdesivir (1)

Sponsors

Alpha Tau Medical LTD. (1)  ·  Mount Sinai Hospital, Canada (1)  ·  National Taiwan University Hospital (1)

Countries

Canada (1)  ·  Israel (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Dr. Sangeeta Mehta, MD, FRCPC (1)  ·  Liron Dimnik (1)